Enabling healthcare’s digital futureDebiopharm Innovation Fund’s Tanja Dowe on investing in digital health start-ups and supporting them on their rollercoaster rides Share XEnabling healthcare’s digital futurehttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/enabling-healthcares-digital-future-debiopharm/
Navigating the NHS as a digital start-upWe speak to finalists from the Greater Manchester Future of Health accelerator to find out how digital start-ups Share XNavigating the NHS as a digital start-uphttps://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/navigating-the-nhs-as-a-digital-start-up/
Building the infrastructure for successful digital health start-ups2020 might go down as the year digital health truly began to boom – but to continue thriving, Share XBuilding the infrastructure for successful digital health start-upshttps://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/building-the-infrastructure-for-successful-digital-health-start-ups/
5 pitfalls AI healthcare start-ups need to avoidArtificial intelligence (AI) has now moved beyond its initial hype towards becoming a key part of the pharma Share X5 pitfalls AI healthcare start-ups need to avoidhttps://pharmaphorum.com/views-analysis-digital/5-pitfalls-ai-healthcare-start-ups-need-to-avoid-early-in-their-journey/
Digital therapeutics start-ups need patience as well as patientsAn entirely new category of medicine is emerging, and a new wave of digital therapeutics start-ups is joining Share XDigital therapeutics start-ups need patience as well as patientshttps://pharmaphorum.com/views-analysis-digital/bayer-g4a-digital-therapeutics-startups/
The sky’s the limit for the right digital health start-upsWhat started out six years ago as a local ‘passion project’ for Bayer to collaborate with Berlin’s digital Share XThe sky’s the limit for the right digital health start-upshttps://pharmaphorum.com/views-analysis-digital/bayer-g4a-digital-health-startups/
AZ’s old R&D site at heart of multimillion pound science property ventureAstraZeneca’s new R&D headquarters in Cambridge may be having teething problems – but ironically the site at Alderley Share XAZ’s old R&D site at heart of multimillion pound science property venturehttps://pharmaphorum.com/news/alderley-park-at-heart-of-multimillion-pound-science-property-venture/
Pfizer Healthcare Hub Challenge 2018 winners announcedA service that helps patients capture and share their experience and outcomes of care, in settings from trials Share XPfizer Healthcare Hub Challenge 2018 winners announcedhttps://pharmaphorum.com/news/pfizer-healthcare-hub-challenge-2018-winners/
Pfizer expands venture arm with $600m cash boostPharma giant Pfizer is injecting $600 million into its venture investment arm in a bid to ramp up Share XPfizer expands venture arm with $600m cash boosthttps://pharmaphorum.com/news/pfizer-expands-venture-arm-cash-boost/
